Do oral peptides work? Which peptides survive the gut
Reviewed 18 sourcesPublished by PepVault
Do oral peptides work? Oral semaglutide, octreotide and desmopressin bioavailability from their labels, beside BPC-157, KPV and TB-500 capsules, in one table.

- Last reviewed
- Sources
- 18
- Questions
- 7
- Compounds
- 8
The short answer
A few peptides work by mouth, and only with engineering behind them: oral semaglutide reaches the blood at 0.4% to 2% of the dose, even with an absorption enhancer and a strict fasting routine. For BPC-157, KPV and TB-500 capsules, no study has measured how much reaches the blood in people. Their oral results come from rats and mice, mostly for the gut itself.
Evidence: Approved drug labels (FDA prescribing information on DailyMed) and small human studies for the approved oral peptides and collagen; lab and animal studies only for BPC-157, KPV and thymosin beta-4 (TB-500) by mouth.

Do oral peptides work?
Some do, and the labels say exactly how well. The number that matters is bioavailability: the share of a swallowed dose that reaches the bloodstream intact, compared with the same dose given into a vein. The table puts the approved oral peptide drugs beside the research capsules people search for.
| Peptide | Studied by mouth in people? | What was measured | The result | Evidence level |
|---|---|---|---|---|
| Oral semaglutide (Rybelsus, Ozempic tablets) | Yes, approved | Absolute bioavailability | 0.4% to 1% for Rybelsus 3, 7 and 14 mg; 1% to 2% for Ozempic tablets 1.5, 4 and 9 mg; peak about 1 hour after the tablet1 | Approved drug label |
| Octreotide (Mycapssa capsules) | Yes, approved | Blood exposure against an injection, in healthy people | A 20 mg capsule gave about the same total exposure as a 0.1 mg injection under the skin, with a peak 33% lower; taken with food, absorption fell about 90%2 | Approved drug label |
| Desmopressin (DDAVP tablets) | Yes, approved | Bioavailability | About 0.16% of an intravenous dose, and about 5% of a nasal dose3 | Approved drug label |
| Linaclotide (Linzess) | Yes, approved | Blood levels | Below the lab's lowest measurable level after 72, 145 or 290 mcg; it works on the gut lining and is meant to stay there4 | Approved drug label |
| Cyclosporine (Sandimmune, Neoral) | Yes, approved | Absolute bioavailability | Under 10% in liver transplant patients to as much as 89% in some kidney transplant patients for Sandimmune; Neoral gives 20% to 50% more total exposure5 | Approved drug label |
| Collagen peptides (food) | Yes, as food | Collagen fragments in the blood | After 9.4 to 23 g, collagen fragments in plasma peaked at 20 to 60 nmol/mL within 1 to 2 hours16 | Small human studies |
| BPC-157 | No published result | Stability in gastric juice; healing in rats given it in drinking water | No human oral blood levels; a 2015 tablet study in healthy volunteers posted no results101112 | Lab and animal studies |
| KPV | No | Colitis in mice given it in drinking water | Less gut inflammation in mice; no human oral study1415 | Lab and animal studies |
| TB-500 (thymosin beta-4) | No | Colitis in mice given thymosin beta-4 by stomach tube | Less gut inflammation in mice; the peptide stayed mostly in the gut; no human oral study18 | Animal study |

The approved tablets have numbers measured in people, and they are small: a few tenths of a percent to 2%, cyclosporine aside. The research peptides have none, and their oral results are about the gut of a rat or a mouse.

Why does the gut break down most peptides?
A peptide is a short chain of amino acids, and the gut is built to cut such chains into pieces: digesting protein is its job. Enzymes in the stomach and small intestine split the chain, and the gut lining keeps most large molecules from crossing into the blood68. A 2026 review sums up the problem: peptides tend to be polar, charged, large and easily cut by enzymes, and together these give low oral bioavailability7.
The review makes a second point. Chemists now design peptides that are potent and long-lasting enough to work even when only a few percent, or less, gets through7. That is how oral semaglutide works at under 2%: the molecule lasts about a week in the body, so a small daily share adds up1. A peptide that clears from the blood in minutes has no such cushion.
Through the nose is a different barrier with its own numbers: the desmopressin label puts its tablets at about 5% of what a nasal dose delivers3.
How does oral semaglutide get through?
Each tablet carries an absorption enhancer, an added ingredient that helps a drug cross the gut lining. For semaglutide it is SNAC (salcaprozate sodium)1. In the maker's studies in people and dogs, semaglutide was absorbed in the stomach, in a small area right next to the dissolving tablet, and only when SNAC was in the tablet. SNAC buffers the acid around the tablet, which shields the peptide from enzymes, and boosts absorption only briefly8.
The label's routine follows from this. In its own studies, semaglutide absorption was higher with 50 mL of water than with 240 mL, and higher the longer people waited before eating1. The label's instructions, in order:

- Take the tablet first thing in the morning, on an empty stomach1.
- Swallow it whole with water only, up to 4 ounces (about 120 mL); do not split, crush or chew it1.
- Wait at least 30 minutes before you eat, drink anything else or take other tablets1.
- If you miss a dose, skip it and take the next one the following day; never take two tablets in one day1.
PepVault logs a tablet or capsule with one tap, with no injection site to pick, records the time you took it, and reminds you at the dose time you set. Log it in PepVault
Rybelsus and Ozempic tablets are not interchangeable milligram for milligram, and the label has separate instructions for moving from the injection to a tablet1. Whether and when to switch is the prescriber's decision. The full comparison of the tablet and the injection is on our semaglutide oral versus injection page.
Which other peptide drugs are taken by mouth?
Each approved one solves the gut in its own way.
- Octreotide, a ring-shaped chain of 8 amino acids, comes in an enteric-coated capsule, one that stays shut in stomach acid and opens further along, filled with an oily mix that includes sodium caprylate. It needs 200 times the injected amount to match an injection's total exposure, and it is taken at least 1 hour before or 2 hours after a meal2.
- Desmopressin is a ring-shaped synthetic version of the hormone vasopressin. Its tablets reach about 0.16% bioavailability, yet in the label's dose studies oral doses of 0.025 to 0.4 mg produced clear effects; the tablets hold 0.1 or 0.2 mg3.
- Cyclosporine is a ring of 11 amino acids made by a fungus. It is the exception in the table, and Neoral adds a formula that forms a fine emulsion the moment it meets water, which raises absorption over the older Sandimmune5.
- Linaclotide, 14 amino acids held in shape by three internal bridges, is not meant to reach the blood at all. It acts on the surface of the gut lining, and in blood tests it stayed below the measurable level, fed or fasting4.

Read together, the labels show three ways through: a compact ring structure, an added absorption enhancer or special coating, or a target inside the gut itself. A 2026 review agrees: the approved oral peptides got there through chemical changes, enhancers or special formulas, not by surviving the stomach alone10. A plain research-peptide capsule carries no enhancer tested in people and has no published blood levels.
Do BPC-157 capsules work?
BPC-157's case rests on one property. The group that discovered it reports that it is native to human gastric juice and stays stable in it for more than 24 hours9. A 2026 review of BPC-157 as a drug candidate calls gastric stability its best-documented property, then adds that surviving the stomach is not enough to reach the blood: intestinal stability, crossing the gut lining and the first pass through the liver are untested, and human oral blood-level data do not exist10.
The oral results are animal results. In rats with a cut knee ligament, BPC-157 given in drinking water improved healing over 90 days, as did injections into the belly cavity and a cream on the injury11. In people, a tablet study in healthy volunteers was registered in December 2015 to measure safety and blood levels; its status is unknown and it has posted no results12. A gummy maker's 8-week study of 40 active adults finished in November 2025, with one group and no blood levels of BPC-157 among its measures; no results are posted as of November 20, 202613.
Commonly reported: BPC-157 capsules taken for stomach and gut complaints, with injections kept for tendons and joints, on the idea that a swallowed dose acts near the gut. These are user reports; no study in people has compared the routes or measured blood levels after a capsule.
The human studies of BPC-157, none of them with a capsule, are in our guide BPC-157: what the human data shows, and the BPC-157 page lists its studies.
What about KPV and TB-500 capsules?
KPV is a chain of just three amino acids, small enough for PepT1, a transporter in the gut lining that carries two- and three-amino-acid pieces of digested protein into cells. In lab tests on human gut and immune cells, KPV entered through PepT1 and damped inflammatory signals. In mice with chemically induced colitis, KPV in drinking water reduced the inflammation14. A later mouse study packed KPV into nanoparticles coated to seek out colon cells and found a stronger effect than uncoated KPV particles15. No study has given KPV by mouth to people.
TB-500 is built on thymosin beta-4, a natural chain of 43 amino acids, and its oral data is one mouse study. In mice with chemically induced colitis, lab-made human thymosin beta-4 given daily by stomach tube improved survival and eased gut inflammation. A tracer showed it stayed mostly in the stomach and gut, reaching the rest of the body far less than an injection into the belly cavity18. No study has given it by mouth to people. Our TB-500 page lists the studies by route.
When to get help Belly pain that does not settle, repeated vomiting, or black or bloody stools are reasons to see a doctor, whatever you are taking.
Are collagen peptides different?
Yes, because collagen peptides are food and are meant to be digested. In healthy volunteers who fasted 12 hours and then took 9.4 to 23 g of gelatin hydrolysate, collagen fragments in the blood rose from almost nothing to 20 to 60 nmol/mL within 1 to 2 hours, then halved by 4 hours. The main fragment was Pro-Hyp, a two-amino-acid piece16.
In a crossover study of 5 men, these fragments made up about 30% of the hydroxyproline, collagen's marker amino acid, measured in the blood, and the amount depended on the source: fish scale gave more than pig skin17. What reaches the blood is pieces two or three amino acids long, not the whole collagen protein16.
Sources
- Rybelsus and Ozempic (semaglutide) tablets. Prescribing information and medication guide. Novo Nordisk. DailyMed, effective January 2026. dailymed.nlm.nih.gov
- Mycapssa (octreotide) delayed-release capsules. Prescribing information. Chiesi USA. DailyMed, effective July 2025. dailymed.nlm.nih.gov
- DDAVP (desmopressin acetate) tablets. Prescribing information. Ferring Pharmaceuticals. DailyMed, effective February 2021. dailymed.nlm.nih.gov
- Linzess (linaclotide) capsules. Prescribing information. Allergan. DailyMed, effective October 2026. dailymed.nlm.nih.gov
- Neoral (cyclosporine) capsules and oral solution. Prescribing information. Novartis. DailyMed, effective August 2026. dailymed.nlm.nih.gov
- Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2020. PubMed 31848464
- Khalid NU et al. Navigating the complexity of oral peptide delivery: challenges and strategies to enhance oral bioavailability. Front Drug Deliv. 2026 (authors employed by an oral-delivery company). PubMed 41953894
- Buckley ST et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci Transl Med. 2018 (Novo Nordisk). PubMed 30429357
- Sikiric P et al. New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. Inflammopharmacology. 2024. PubMed 38980576
- Mateescu DM et al. BPC-157 as an investigational peptide therapeutic: biopharmaceutical challenges, formulation strategies, and translational development barriers. Pharmaceutics. 2026. PubMed 42198317
- Cerovecki T et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010. PubMed 20225319
- PCO-02 safety and pharmacokinetics trial (oral BPC-157 tablets in healthy volunteers). ClinicalTrials.gov NCT02637284. clinicaltrials.gov
- A clinical trial to evaluate the effects of peptide gummies on markers of inflammation, physical performance, and recovery. ClinicalTrials.gov NCT07752381. clinicaltrials.gov
- Dalmasso G et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008. PubMed 18061177
- Xiao B et al. Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis. Mol Ther. 2017. PubMed 28143741
- Iwai K et al. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J Agric Food Chem. 2005. PubMed 16076145
- Ohara H et al. Comparison of quantity and structures of hydroxyproline-containing peptides in human blood after oral ingestion of gelatin hydrolysates from different sources. J Agric Food Chem. 2007. PubMed 17253720
- Zhao TR et al. Recombinant human thymosin beta-4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling. Mol Biomed. 2026. PubMed 42606759
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.